Intervention

Metformin

Emerging evidence

Metformin is a widely used, inexpensive type 2 diabetes drug being studied as a potential geroprotector. Its anti-ageing benefit in non-diabetics is unproven and is the subject of the planned TAME trial.

Also known as: metformin, glucophage

What metformin is

Metformin is a first-line, low-cost medication for type 2 diabetes that lowers blood glucose mainly by reducing the liver's glucose output and improving insulin sensitivity. It has decades of safety data.

Why it matters for longevity

Observational data once suggested some diabetics on metformin outlived non-diabetics, sparking interest in it as a “geroprotector” that influences nutrient-sensing pathways related to mTOR and AMPK. The proposed TAME (Targeting Aging with Metformin) trial is designed to test whether it delays age-related disease.

What the evidence shows

For diabetes the benefit is established. For *longevity in healthy people* the evidence is Emerging and contested — some studies even suggest it may blunt the gains from exercise. No completed trial shows metformin extends healthy human lifespan.

What to ask a clinic

Off-label metformin for longevity is a medical decision: discuss your metabolic profile, vitamin B12 monitoring, GI side-effects, and the (currently unproven) rationale with a clinician.

Sources & references

  1. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metabolism. 2016. doi:10.1016/j.cmet.2016.05.011

Related treatments

Clinics offering this

Related terms

Educational information, not medical advice. Evidence ratings follow our methodology.